Recent pharmacological progress ofGinkgo biloba extract for cardiovascular and neuronal diseases

Xiu Chen; Wei-Zhou Chen

doi:10.1007/BF02934707

Your Location：

Home >

Browse articles >

Recent pharmacological progress ofGinkgo biloba extract for cardiovascular and neuronal diseases

OriginalPaper | Updated：2021-08-27

- Recent pharmacological progress ofGinkgo biloba extract for cardiovascular and neuronal diseases
- Recent pharmacological progress ofGinkgo biloba extract for cardiovascular and neuronal diseases
- 中国结合医学杂志（英文版） 1996年2卷第4期页码：300-304
- Affiliations：
  
  1. Department of Pharmacology, Hunan Medical University,Changsha
  2. Department of Pharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences,Shanghai
- Author bio：
- Funds：
- DOI：10.1007/BF02934707
  中图分类号：
- 纸质出版日期：1996，
Scan for full text
Chen, X., Chen, WZ. Recent pharmacological progress ofGinkgo biloba extract for cardiovascular and neuronal diseases., CJIM 2, 300–304 (1996). https://doi.org/10.1007/BF02934707

Xiu Chen, Wei-Zhou Chen. Recent pharmacological progress ofGinkgo biloba extract for cardiovascular and neuronal diseases[J]. Chinese Journal of Integrative Medicine, 1996,2(4):300-304.
Chen, X., Chen, WZ. Recent pharmacological progress ofGinkgo biloba extract for cardiovascular and neuronal diseases., CJIM 2, 300–304 (1996). https://doi.org/10.1007/BF02934707 DOI：

Xiu Chen, Wei-Zhou Chen. Recent pharmacological progress ofGinkgo biloba extract for cardiovascular and neuronal diseases[J]. Chinese Journal of Integrative Medicine, 1996,2(4):300-304. DOI： 10.1007/BF02934707.

摘要

Abstract

关键词

DPPHPlatelet Activate FactorMyricetinIntermittent ClaudicationGinkgo Biloba Extract

Keywords

DPPHPlatelet Activate FactorMyricetinIntermittent ClaudicationGinkgo Biloba Extract

references

Itil T, Martorano D. Natural substances in psychiatry (Ginkgo biloba in Dementia). Psychopharmacol Bulletin 1995; 31:147.

Kleijnen J, Knipsichild P.Ginkgo biloba. Lancet 1992; 340:1136.

1994; 9:10.

Braquet P, Hosford D. Ethnopharmacology and the development of natural PAF antagonists as therapeutic agents. J Ethnopharmacol 1991; 32:135.

Auguest M, Delaflotte S, Hellegouarch A, et al. The pharmacological basis for the vascular impact ofGinkgo biloba extract. In: Funfgeld EW(ed), Rokan (Ginkgo Biloba). Recent results in pharmacology and clinic. Berlin, Heidelberg, New York: Springer-Verlag, 1988:169–179

Chen FY, Lee T J-F. Role of nitric oxide in neurogenic vasodilation of porcine cerebral artery. J Pharmacol Exper Ther 1993; 265:339–345

Marcocci L, Maguire JJ, Droy-Lefaix MT et al. The nitric oxide -scavenging properties ofGinkgo biloba extract EGb 761. Biochem Biophy Res Commun 1994; 201:748.

1995;15(5):320.

Spinnewyn B, et al. Effects ofGinkgo biloba on a cerebral ischemia model in gerbils. In: Funfgeld EW(ed), Rokan (Ginkgo Biloba). Recent results in pharmacology and clinic. Berlin, Heidelberg, New York: Springer-Verlag, 1988: 143–152

Smith PF, Maclennan K, Darington CL. The neuroprotective properties of theGinkgo biloba leaf: a review of the possible relationship to platelet-activating factor (PAF). J Ethnopharmacol 1996;50:131.

Etienne A, Hecquet F, Clostre F. Mechanisms of effect ofGinkgo biloba extract on experimental cerebraledema. In: Funfgeld EW(ed), Rokan (Ginkgo Biloba). Recent results in pharmacology and clinic. Berlin, Heidelberg, New York: Springer-Verlag, 1988:133–142.

Tighilet B, Lacour M. Pharmacological activity of theGinkgo biloba extract (EGb 761) on equilibrium function recovery in the unilateral neurectomized cat. J Vestibular Res 1995;5:187.

Maclennenan K, Smith PF, Darlington CL. Ginkgolides B accelerates vestibular compensation of spontaneous ocular nystagmus in guinea-pig following unilateral labyrinthectomy. Exper Neurol 1995; 131:273.

Oyama Y, Fuchs PA, Katayama N, et al. Myricetin and quercetin, the flavonoid constitutes ofGinkgo biloba extract, greatly reduce oxidative metabolism in both resting and Ca2+ -loaded brain neurons. Brain Res 1994;635:125.

Guillon JM, Rochette L, Baranes J. Effects ofGinkgo biloba extract on two models of experimental myocardial ischemia. In: Funfgeld EW (ed), Rokan (Ginkgo Biloba). Recent results in pharmacology and clinic. Berlin, Heidelberg, New York: Springer-Verlag, 1988:153–161.

Haramaki N, et al. Effects of natural antioxidantGinkgo biloba extract (EGB 761) on myocardial ischemia/reperfusion injury. Free Radical Biol Med 1994; 16:789.

Tosaki Al.Ginkgo biloba extract (EGb 761) improves postischemic function in isolated preconditioned working rat hearts. Coronary Artery Dis 1994; 5:443.

Robak J, Gryglewski RJ. Flavonoids are scavengers of superoxide anions. Biochem Pharmacol 1988;37:837.

Ratty AK, et al. Interaction of flavonoids with 1, lDiphenyl-2-picryl hydrazyl free radical, liposomal membrane and soy bean lipoxygenase-I. Biochem Pharmacol 1988; 37:989–995.

Pincemail J, Deby C. The antiradical properties ofGinkgo biloba extract. In: Funfgeld EW(ed), Rökan (Ginkgo Biloba). Recent results in pharmacology and clinic. Berlin, Heidelberg, New York: Springer-Verlag, 1988:71–82.

Maitra I, et al. Peroxyl radical scavenging activity ofGinkgo biloba extract EGb 761. Biochem Pharmacol 1995; 49:1649.

Bolli R. Oxygen derived free radicals and myocardial reperfusion injury: an overview. Cardiovasc Drugs Ther 1991; 5:249–268.

Chen X, Liu LY, Cai CQ. Ramprilat preconditions the DPPH free radical-damaged aortic endothelium. J Mol Cell Cardio 1995; 27(6):A156.

Yan LJ, Droy-Lefaix MT, Packer L.Ginkgo biloba extract (EGB 761) protects human low density lipoproteins against oxidative modification mediated by copper. Biochem Biophy Res Commun 1995;212:360.

Dumont E, D’Arbigny P, Nouvelot A. Protection of polysaturated fatty acids against iron-dependent lipid peroxidation by aGinkgo biloba extract (EGB 761). Methods and Findings in Exp and Clin Pharmacol 1995;17:83.

Shen J-G, Zhou DY. Efficiency ofGinkgo biloba extract (EGB 761) in antioxidant protection against myocardial is chemia and reperfusion injury. Biochem and Mol Biol International. 1995;35:125.

Allard M. Treatment of old age disorders withGinkgo biloba extract. From Pharmacology to clinic. In: Funfgeld EW(ed), Rokan (Ginkgo Biloba). Recent results in pharmacology and clinic. Berlin, Heidelberg, New York: Springer-Verlag, 1988:201–211.

Petkov VD, et al. Memory effects of standardized extracts ofPanax ginseng (G115),Ginkgo biloba (GK 501) and their combination Gincosan (PHL-00701). Planta Medica 1993; 59:106.

FULL TEXT LINK

More>

浏览量

1307

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Effects of Ginkgo biloba extract on periodontal pathogens and its clinical efficacy as adjuvant treatment

Clinical study on protective effect of ginaton on ischemia-reperfusion injured myocardium during cardiopulmonary bypass

Relationship between endothelin-1 and ischemic brain damage after subarachnoid hemorrhage and protective effect of Ginkgo biloba extract

Academic summary of the world integrated medicine congress